RESEARCH IN ENGLAND
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
421 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT05091424 · Interventional
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Study overall: Recruiting · source record updated 8 September 2026.
2 England locations · 2 explicitly recorded as recruiting.
NCT05104515 · Interventional
Prostate Cancer · Non Small Cell Lung Cancer · Ovarian Cancer
Study overall: Recruiting · source record updated 14 February 2025.
4 England locations · 3 explicitly recorded as recruiting.
NCT05107674 · Interventional
Ovarian Cancer, Epithelial · Gastric Cancer · GastroEsophageal Junction (GEJ) Cancer · Head and Neck Squamous Cell Carcinoma · Metastatic or Unresectable Melanoma · Non-small Cell Lung Cancer (NSCLC) · Metastatic Castration-resistant Prostate Cancer (mCRPC) · Malignant Pleural Mesothelioma (MPM) · Triple Negative Breast Cancer (TNBC) · Metastatic Urothelial Carcinoma · Cervical Cancer · Diffuse Large B Cell Lymphoma (DLBCL) · Richter Transformation · Microsatellite Stable Colorectal Carcinoma
Study overall: Recruiting · source record updated 9 September 2025.
6 England locations · 5 explicitly recorded as recruiting.
NCT05118789 · Interventional
Locally Advanced Solid Tumor · Metastatic Solid Tumor
Study overall: Recruiting · source record updated 24 October 2025.
2 England locations · 2 explicitly recorded as recruiting.
NCT05130437 · Interventional
Propionic Acidemia
Study overall: Recruiting · source record updated 23 March 2026.
4 England locations · 3 explicitly recorded as recruiting.
NCT05131022 · Interventional
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Diffuse Large B Cell Lymphoma (DLBCL) · Follicular Lymphoma (FL) · Mantle Cell Lymphoma (MCL) · Marginal Zone Lymphoma (MZL) · Waldenstrom Macroglobulinemia (WM) · Primary Central Nervous System Lymphoma (PCNSL) · Secondary Central Nervous System Lymphoma (SCNSL)
Study overall: Recruiting · source record updated 2 July 2026.
9 England locations · 9 explicitly recorded as recruiting.
NCT05163288 · Interventional
Niemann-Pick Disease, Type C
Study overall: Recruiting · source record updated 3 April 2026.
3 England locations · 0 explicitly recorded as recruiting.
NCT05197322 · Interventional
Adenocarcinoma of the Colon
Study overall: Recruiting · source record updated 17 April 2026.
5 England locations · 3 explicitly recorded as recruiting.
NCT05208047 · Interventional
Advanced Gastrointestinal Stromal Tumors · Metastatic Cancer
Study overall: Recruiting · source record updated 16 June 2026.
6 England locations · 0 explicitly recorded as recruiting.
NCT05253651 · Interventional
Colorectal Neoplasms
Study overall: Recruiting · source record updated 22 July 2026.
10 England locations · 10 explicitly recorded as recruiting.
NCT05272709 · Interventional
Advanced Solid Tumors
Study overall: Recruiting · source record updated 12 August 2026.
3 England locations · 3 explicitly recorded as recruiting.
NCT05295433 · Interventional
Methylmalonic Acidemia
Study overall: Recruiting · source record updated 23 December 2025.
2 England locations · 1 explicitly recorded as recruiting.
NCT05304377 · Interventional
Chronic Myeloid Leukemia · Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Cml
Study overall: Recruiting · source record updated 1 April 2026.
2 England locations · 2 explicitly recorded as recruiting.
NCT05319353 · Interventional
Cytomegalovirus (CMV)
Study overall: Recruiting · source record updated 22 May 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT05339360 · Observational
Femur Fracture · Osteotomy
Study overall: Recruiting · source record updated 25 November 2025.
1 England locations · 1 explicitly recorded as recruiting.
NCT05372354 · Interventional
Multiple Myeloma
Study overall: Recruiting · source record updated 5 September 2025.
5 England locations · 3 explicitly recorded as recruiting.
NCT05383287 · Observational
Heart Failure With Preserved Ejection Fraction (HFpEF)
Study overall: Recruiting · source record updated 1 October 2025.
1 England locations · 1 explicitly recorded as recruiting.
NCT05384626 · Interventional
Locally Advanced Solid Tumor · Metastatic Solid Tumor
Study overall: Recruiting · source record updated 27 May 2026.
3 England locations · 3 explicitly recorded as recruiting.
NCT05386108 · Interventional
Breast Neoplasms · Brain Neoplasms · Neoplasms by Site · Neoplasms · Breast Diseases · Central Nervous System Neoplasms · Brain Diseases · Central Nervous System Diseases
Study overall: Recruiting · source record updated 9 September 2026.
5 England locations · 3 explicitly recorded as recruiting.
NCT05405868 · Interventional
Glaucoma, Open-Angle
Study overall: Recruiting · source record updated 9 May 2024.
9 England locations · 4 explicitly recorded as recruiting.
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.